The European Molecular Biology Laboratory (EMBL) is one of the world’s leading research institutions, and Europe’s flagship laboratory for the life sciences. 
EMBL is an intergovernmental organisation specialising in basic research in the life sciences, funded by public research monies from more than 20 member states, including much of Europe and Israel, and two associate members, Argentina and Australia. EMBL operates from six sites across Europe: Heidelberg, Germany - main laboratory; Hinxton, UK - European Bioinformatics Institute (EMBL-EBI); Grenoble, France - research and services for structural biology; Hamburg, Germany - research and services for structural biology; Rome, Italy - epigenetics and neurobiology and Barcelona, Spain - tissue biology and disease modelling
EMBL believes that excellent basic research requires continuous training and exchange with other experts, and actively engage in advanced training activities like conferences and hands-on courses that enable scientists to improve their skills and expand their horizons, both within and outside EMBL. The technology portfolio spans the life sciences in the broadest sense and includes enabling technologies, molecular tools, techniques, instruments and software programs and databases.
EMBL’s mission is to be at the forefront of life sciences research, technology development and transfer, and to provide outstanding training and services to the scientific community in member states.